BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37946565)

  • 21. Cost-effectiveness of personalised telehealth intervention for chronic disease management: A pilot randomised controlled trial.
    Mudiyanselage SB; Stevens J; Toscano J; Kotowicz MA; Steinfort CL; Hayles R; Watts JJ
    PLoS One; 2023; 18(6):e0286533. PubMed ID: 37319290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness analysis for a tele-based health coaching program for chronic disease in primary care.
    Oksman E; Linna M; Hörhammer I; Lammintakanen J; Talja M
    BMC Health Serv Res; 2017 Feb; 17(1):138. PubMed ID: 28202032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An economic evaluation of a telephone outcall intervention for informal carers of cancer patients in Australia: An assessment of costs and quality-adjusted-life-years.
    Richards-Jones S; Mihalopoulos C; Heckel L; Gunn KM; Tan M; Livingston PM
    Psychooncology; 2019 Mar; 28(3):525-532. PubMed ID: 30600865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of habit-based advice for weight control versus usual care in general practice in the Ten Top Tips (10TT) trial: economic evaluation based on a randomised controlled trial.
    Patel N; Beeken RJ; Leurent B; Omar RZ; Nazareth I; Morris S
    BMJ Open; 2018 Aug; 8(8):e017511. PubMed ID: 30104307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of a pragmatic structured education intervention for the prevention of type 2 diabetes: economic evaluation of data from the Let's Prevent Diabetes cluster-randomised controlled trial.
    Leal J; Ahrabian D; Davies MJ; Gray LJ; Khunti K; Yates T; Gray AM
    BMJ Open; 2017 Jan; 7(1):e013592. PubMed ID: 28069625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness and cost-utility of a Web-based or print-delivered tailored intervention to promote physical activity among adults aged over fifty: an economic evaluation of the Active Plus intervention.
    Golsteijn RH; Peels DA; Evers SM; Bolman C; Mudde AN; de Vries H; Lechner L
    Int J Behav Nutr Phys Act; 2014 Sep; 11():122. PubMed ID: 25262435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-utility analysis of a structured medication review compared to usual care in Parkinson's disease.
    Oonk NGM; Dorresteijn LDA; van den Berg AD; van der Palen J; Movig KLL; Nijmeijer HW; van Kesteren ME; Koffijberg H
    Eur J Clin Pharmacol; 2023 Feb; 79(2):289-297. PubMed ID: 36562830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-Effectiveness of Facilitated Access to a Self-Management Website, Compared to Usual Care, for Patients With Type 2 Diabetes (HeLP-Diabetes): Randomized Controlled Trial.
    Li J; Parrott S; Sweeting M; Farmer A; Ross J; Dack C; Pal K; Yardley L; Barnard M; Hudda M; Alkhaldi G; Murray E
    J Med Internet Res; 2018 Jun; 20(6):e201. PubMed ID: 29884608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A trial-based economic evaluation of the Restore4Stroke self-management intervention compared to an education-based intervention for stroke patients and their partners.
    van Mastrigt GAPG; van Eeden M; van Heugten CM; Tielemans N; Schepers VPM; Evers SMAA
    BMC Health Serv Res; 2020 Apr; 20(1):294. PubMed ID: 32268896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of guideline-based stepped and collaborative care versus treatment as usual for patients with depression - a cluster-randomized trial.
    Brettschneider C; Heddaeus D; Steinmann M; Härter M; Watzke B; König HH
    BMC Psychiatry; 2020 Aug; 20(1):427. PubMed ID: 32859177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility and acceptability of a telehealth platform for delivering the Making Sense of Brain Tumour programme: A mixed-methods pilot study.
    Ownsworth T; Cubis L; Prasad T; Foote M; Kendall M; Oram J; Chambers S; Pinkham MB
    Neuropsychol Rehabil; 2022 Apr; 32(3):378-406. PubMed ID: 33000690
    [No Abstract]   [Full Text] [Related]  

  • 33. Cost-effectiveness analysis of systematic fast-track transition from oncological treatment to specialised palliative care at home for patients and their caregivers: the DOMUS trial.
    Halling CMB; Wolf RT; Sjøgren P; Von Der Maase H; Timm H; Johansen C; Kjellberg J
    BMC Palliat Care; 2020 Sep; 19(1):142. PubMed ID: 32933489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Costs and Cost-effectiveness of Collaborative Care for Adolescents With Depression in Primary Care Settings: A Randomized Clinical Trial.
    Wright DR; Haaland WL; Ludman E; McCauley E; Lindenbaum J; Richardson LP
    JAMA Pediatr; 2016 Nov; 170(11):1048-1054. PubMed ID: 27654449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary trabeculectomy versus primary glaucoma eye drops for newly diagnosed advanced glaucoma: TAGS RCT.
    King AJ; Fernie G; Hudson J; Kernohan A; Azuara-Blanco A; Burr J; Homer T; Shabaninejad H; Sparrow JM; Garway-Heath D; Barton K; Norrie J; McDonald A; Vale L; MacLennan G
    Health Technol Assess; 2021 Nov; 25(72):1-158. PubMed ID: 34854808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A general practice intervention for people at risk of poor health outcomes: the Flinders QUEST cluster randomised controlled trial and economic evaluation.
    Reed RL; Roeger L; Kwok YH; Kaambwa B; Allison S; Osborne RH
    Med J Aust; 2022 May; 216(9):469-475. PubMed ID: 35388512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Trial-Based Cost-Utility Analysis of a Medication Optimization Intervention Versus Standard Care in Older Adults.
    Robinson EG; Gyllensten H; Johansen JS; Havnes K; Granas AG; Bergmo TS; Småbrekke L; Garcia BH; Halvorsen KH
    Drugs Aging; 2023 Dec; 40(12):1143-1155. PubMed ID: 37991657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microdiscectomy Is More Cost-effective Than a 6-Month Nonsurgical Care Regimen for Chronic Radiculopathy.
    Glennie RA; Urquhart JC; Koto P; Rasoulinejad P; Taylor D; Sequeira K; Miller T; Watson J; Rosedale R; Bailey SI; Gurr KR; Siddiqi F; Bailey CS
    Clin Orthop Relat Res; 2022 Mar; 480(3):574-584. PubMed ID: 34597280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial.
    Camacho EM; Ntais D; Coventry P; Bower P; Lovell K; Chew-Graham C; Baguley C; Gask L; Dickens C; Davies LM
    BMJ Open; 2016 Oct; 6(10):e012514. PubMed ID: 27855101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.